首页 > 最新文献

Expert review of medical devices最新文献

英文 中文
Continuous glucose monitoring predicts glycemic status in postpartum women with a recent history of gestational diabetes. 连续血糖监测预测近期妊娠糖尿病史的产后妇女的血糖状态。
IF 2.7 Pub Date : 2026-01-01 Epub Date: 2025-12-26 DOI: 10.1080/17434440.2025.2607631
Karen E Elkind-Hirsch, Melissa L Armatta, Kazanna C Hames, Edward W Veillon

Background: Women with a history of gestational diabetes mellitus (GDM) face an elevated risk of developing diabetes, yet postpartum screening is often This study evaluated the diagnostic utility of a blinded continuous glucose monitoring (CGM) system (Dexcom G7) for assessing glycemic status.

Methods: Of 40 enrolled participants, 39 completed testing at 6-24 weeks postpartum. Assessments included hemoglobin A1c (HbA1c,), fructosamine, a 75-g oral glucose tolerance test (OGTT), and 8-9 days of CGM wear. CGM metrics analyzed were mean glucose and time in range (TIR; 3.9-7.8 mmol/L).

Results: Diabetes and prediabetes were identified in 1 and 9 participants by HbA1c, 3 and 10 by fructosamine, and 4 and 10 by OGTT. CGM metrics detected 4 cases of diabetes and 10 of prediabetes. Mean OGTT glucose correlated strongly with mean CGM glucose (r = 0.66, p < 0.001) and inversely with TIR (r = -0.57, p < 0.001). Paired OGTT and CGM values were highly correlated (r = 0.874; p < 0.001).

Conclusion: Postpartum dysglycemia is prevalent after GDM. HbA1c and fructosamine lacked sensitivity and specificity, while CGM performed comparably to OGTT in detecting abnormal glucose metabolism in this postpartum population.Clinical trial registration: www.clinicaltrials.gov identifier is NCT06057805.

背景:有妊娠期糖尿病(GDM)病史的女性患糖尿病的风险较高,但产后筛查经常进行。本研究评估了盲法连续血糖监测(CGM)系统(Dexcom G7)在评估血糖状态方面的诊断效用。方法:40名参与者中,39名在产后6-24周完成测试。评估包括血红蛋白A1c (HbA1c)、果糖胺、75克口服葡萄糖耐量试验(OGTT)和8-9天的CGM磨损。分析的CGM指标为平均血糖和时间范围(TIR; 3.9-7.8 mmol/L)。结果:1名和9名参与者通过HbA1c, 3名和10名通过果糖胺,4名和10名通过OGTT诊断为糖尿病和前驱糖尿病。CGM指标检测到4例糖尿病和10例前驱糖尿病。平均OGTT血糖与平均CGM血糖呈正相关(r = 0.66, pr = -0.57, pr = 0.874; p结论:GDM后产后血糖异常普遍。HbA1c和果糖胺缺乏敏感性和特异性,而CGM在检测产后人群糖代谢异常方面的表现与OGTT相当。临床试验注册:http://www.clinicaltrials.gov标识符:NCT06057805。
{"title":"Continuous glucose monitoring predicts glycemic status in postpartum women with a recent history of gestational diabetes.","authors":"Karen E Elkind-Hirsch, Melissa L Armatta, Kazanna C Hames, Edward W Veillon","doi":"10.1080/17434440.2025.2607631","DOIUrl":"10.1080/17434440.2025.2607631","url":null,"abstract":"<p><strong>Background: </strong>Women with a history of gestational diabetes mellitus (GDM) face an elevated risk of developing diabetes, yet postpartum screening is often This study evaluated the diagnostic utility of a blinded continuous glucose monitoring (CGM) system (Dexcom G7) for assessing glycemic status.</p><p><strong>Methods: </strong>Of 40 enrolled participants, 39 completed testing at 6-24 weeks postpartum. Assessments included hemoglobin A1c (HbA1c,), fructosamine, a 75-g oral glucose tolerance test (OGTT), and 8-9 days of CGM wear. CGM metrics analyzed were mean glucose and time in range (TIR; 3.9-7.8 mmol/L).</p><p><strong>Results: </strong>Diabetes and prediabetes were identified in 1 and 9 participants by HbA1c, 3 and 10 by fructosamine, and 4 and 10 by OGTT. CGM metrics detected 4 cases of diabetes and 10 of prediabetes. Mean OGTT glucose correlated strongly with mean CGM glucose (<i>r</i> = 0.66, <i>p</i> < 0.001) and inversely with TIR (<i>r</i> = -0.57, <i>p</i> < 0.001). Paired OGTT and CGM values were highly correlated (<i>r</i> = 0.874; <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Postpartum dysglycemia is prevalent after GDM. HbA1c and fructosamine lacked sensitivity and specificity, while CGM performed comparably to OGTT in detecting abnormal glucose metabolism in this postpartum population.<b>Clinical trial registration:</b> www.clinicaltrials.gov identifier is NCT06057805.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"99-105"},"PeriodicalIF":2.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145807025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echocardiographic assessment after transcatheter aortic valve replacement. 经导管主动脉瓣置换术后超声心动图评价。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-09-29 DOI: 10.1080/17434440.2025.2567546
Kevin Gu, Abdulrahman Museedi, Vratika Agarwal, Rebecca T Hahn

Introduction: Aortic stenosis is one of the most common valvular diseases, especially in the elderly. Transcatheter aortic valve replacement (TAVR) has become a mainstay treatment of severe, symptomatic aortic stenosis. Echocardiography remains the critical diagnostic tool for procedural success, complications, and follow-up.

Areas covered: In this review, we discuss the use of echocardiography for the assessment of transcatheter aortic valve (TAV) function. We summarize currently available data on expected mean gradients and effective orifice area in various valve types and sizes and how it may differ from invasive measurements. We also summarize the complexities of quantifying paravalvular TAV regurgitation and its impact on clinical outcomes.

Expert opinion: The hemodynamics of a transcatheter aortic valve is highly dependent on the inflow fluid dynamics. Although high gradients are undesirable, it does not necessary correlate to worse outcomes and should be taken into account with other parameters for assessment of valve function. Accurate diagnosis of bioprosthetic valve degeneration and failure is crucial as the TAVR patient shifts to younger and less co-morbid population.

主动脉瓣狭窄是最常见的瓣膜疾病之一,尤其是在老年人中。经导管主动脉瓣置换术(TAVR)已成为治疗严重症状性主动脉瓣狭窄的主要方法。超声心动图仍然是手术成功、并发症和随访的关键诊断工具。涵盖的领域:在这篇综述中,我们讨论了超声心动图在经导管主动脉瓣(TAV)功能评估中的应用。我们总结了目前可获得的关于各种阀门类型和通径的预期平均梯度和有效孔面积的数据,以及它与侵入性测量的差异。我们还总结了量化瓣旁反流的复杂性及其对临床结果的影响。专家意见:经导管主动脉瓣的血流动力学高度依赖于流入流体动力学。虽然高梯度是不可取的,但它不一定与较差的结果相关,应与评估瓣膜功能的其他参数一起考虑。随着TAVR患者转向更年轻和更少合并症的人群,准确诊断生物假体瓣膜变性和衰竭至关重要。
{"title":"Echocardiographic assessment after transcatheter aortic valve replacement.","authors":"Kevin Gu, Abdulrahman Museedi, Vratika Agarwal, Rebecca T Hahn","doi":"10.1080/17434440.2025.2567546","DOIUrl":"10.1080/17434440.2025.2567546","url":null,"abstract":"<p><strong>Introduction: </strong>Aortic stenosis is one of the most common valvular diseases, especially in the elderly. Transcatheter aortic valve replacement (TAVR) has become a mainstay treatment of severe, symptomatic aortic stenosis. Echocardiography remains the critical diagnostic tool for procedural success, complications, and follow-up.</p><p><strong>Areas covered: </strong>In this review, we discuss the use of echocardiography for the assessment of transcatheter aortic valve (TAV) function. We summarize currently available data on expected mean gradients and effective orifice area in various valve types and sizes and how it may differ from invasive measurements. We also summarize the complexities of quantifying paravalvular TAV regurgitation and its impact on clinical outcomes.</p><p><strong>Expert opinion: </strong>The hemodynamics of a transcatheter aortic valve is highly dependent on the inflow fluid dynamics. Although high gradients are undesirable, it does not necessary correlate to worse outcomes and should be taken into account with other parameters for assessment of valve function. Accurate diagnosis of bioprosthetic valve degeneration and failure is crucial as the TAVR patient shifts to younger and less co-morbid population.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1379-1389"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in minimally traumatic retinal laser therapy. 微创视网膜激光治疗的研究进展。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-11-10 DOI: 10.1080/17434440.2025.2586750
Catherine S Yao, Yannis M Paulus

Introduction: Retinal laser therapy has played a key role in managing numerous retinal vascular diseases, such as diabetic retinopathy, retinal vein occlusion, macular edema, and central serous chorioretinopathy since the 1960s. While conventional laser approaches are shown to be effective, they have been associated with permanent tissue scarring and vision loss. Recent advancements aim to minimize this collateral damage, using subdamaging or selective energy delivery to preserve healthy retina while balancing treatment benefit.

Areas covered: This review summarizes novel minimally traumatic retinal laser therapies, including micropulse lasers, selective retina therapy, nanosecond lasers, and other advanced laser and delivery systems. Although supporting clinical studies remains relatively small and longer follow-up is needed for clinical standardization, early results are promising, pointing toward safer and more effective retinal laser treatments options. A literature search of PubMed/MEDLINE and Embase was conducted for studies published up to July 2025.

Expert opinion: Minimally traumatic retinal lasers offer a promising adjunctive or alternative treatment for pharmacologic treatments with vision-preserving outcomes with reduced procedural burden. As ongoing research continues to validate safety and efficacy, these therapies will continue to play a critical role in the dynamic field of retinal disease management.

自20世纪60年代以来,视网膜激光治疗在许多视网膜血管疾病的治疗中发挥了关键作用,如糖尿病视网膜病变、视网膜静脉闭塞、黄斑水肿和中枢性浆液性脉络膜视网膜病变。虽然传统的激光方法被证明是有效的,但它们与永久性组织瘢痕和视力丧失有关。最近的进展旨在最大限度地减少这种附带损伤,使用亚损伤或选择性能量输送来保持健康的视网膜,同时平衡治疗效益。涵盖领域:本文综述了新型微创视网膜激光治疗方法,包括微脉冲激光、选择性视网膜治疗、纳秒激光和其他先进的激光和传输系统。尽管支持的临床研究仍然相对较小,临床标准化需要更长时间的随访,但早期的结果是有希望的,指出了更安全,更有效的视网膜激光治疗选择。在PubMed/MEDLINE和Embase检索截至2025年7月发表的研究。专家意见:微创视网膜激光为药物治疗提供了一种有希望的辅助或替代治疗方法,在减少手术负担的同时,还能保持视力。随着正在进行的研究继续验证安全性和有效性,这些疗法将继续在视网膜疾病管理的动态领域发挥关键作用。
{"title":"Advances in minimally traumatic retinal laser therapy.","authors":"Catherine S Yao, Yannis M Paulus","doi":"10.1080/17434440.2025.2586750","DOIUrl":"10.1080/17434440.2025.2586750","url":null,"abstract":"<p><strong>Introduction: </strong>Retinal laser therapy has played a key role in managing numerous retinal vascular diseases, such as diabetic retinopathy, retinal vein occlusion, macular edema, and central serous chorioretinopathy since the 1960s. While conventional laser approaches are shown to be effective, they have been associated with permanent tissue scarring and vision loss. Recent advancements aim to minimize this collateral damage, using subdamaging or selective energy delivery to preserve healthy retina while balancing treatment benefit.</p><p><strong>Areas covered: </strong>This review summarizes novel minimally traumatic retinal laser therapies, including micropulse lasers, selective retina therapy, nanosecond lasers, and other advanced laser and delivery systems. Although supporting clinical studies remains relatively small and longer follow-up is needed for clinical standardization, early results are promising, pointing toward safer and more effective retinal laser treatments options. A literature search of PubMed/MEDLINE and Embase was conducted for studies published up to July 2025.</p><p><strong>Expert opinion: </strong>Minimally traumatic retinal lasers offer a promising adjunctive or alternative treatment for pharmacologic treatments with vision-preserving outcomes with reduced procedural burden. As ongoing research continues to validate safety and efficacy, these therapies will continue to play a critical role in the dynamic field of retinal disease management.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1293-1302"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145453664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of mid-term survival of uncemented total knee arthroplasties with modular tibial components made of porous tantalum vs. cemented total knee arthroplasties. 多孔钽模数胫骨假体与骨水泥全膝关节置换术的中期生存率比较。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-10-06 DOI: 10.1080/17434440.2025.2569571
Žiga Godicelj, Jure Kastelic, Vesna Levašič, Zmago Krajnc, Andrej Moličnik, Igor Novak, Jakob Naranđa, Jan Zajc, Samo K Fokter

Background & objectives: Cementless total knee arthroplasties (TKAs) with porous tantalum tibial components were developed to improve fixation and reduce implant failure rates in younger, active patients. However, mid-term outcomes remain uncertain. This retrospective study compared survival rates of cementless TKAs with porous tantalum posterior-stabilized (PS) modular tibial components to cemented PS components from the same implant system, using revision for aseptic loosening as the endpoint.

Materials and methods: From January 2017 to November 2021, 899 TKAs were performed at a single tertiary center for osteoarthritis. Of these, 645 (71.7%) were cemented and 254 (28.3%) cementless. Median BMI was similar in both groups (30.0 kg/m2 vs 31.0 kg/m2; p = 0.814). Cementless recipients were younger (median 66.0 vs. 72.0 years; p < 0.001). Follow-up continued through 31 December 2023.

Results: Seven-year survival was lower in the cementless group (97.1%, 95% CI 94.9-99.3) vs. cemented group (97.8%, 95% CI 96.6-99.0). Tibial component loosening led to 5 revisions in the cementless group vs. 2 revisions in the cemented group (p < 0.05). Two cementless cases involved tibial tray fractures. Overall, 86 patients (9.6%) died of unrelated causes.

Conclusions: Cementless porous tantalum TKAs had inferior mid-term performance for aseptic loosening, prompting their discontinuation at our institution.

背景与目的:采用多孔钽胫骨假体的无骨水泥全膝关节置换术(tka)用于改善年轻、活跃患者的固定和降低假体失败率。然而,中期结果仍然不确定。本回顾性研究比较了采用多孔钽后稳定(PS)模块胫骨组件的无骨水泥tka与采用同一种植体系统的骨水泥PS组件的生存率,并以无菌松动翻修为终点。材料和方法:2017年1月至2021年11月,在单一三级骨关节炎中心进行899例tka。其中645例(71.7%)骨水泥,254例(28.3%)无骨水泥。两组的中位BMI相似(30.0 kg/m2 vs 31.0 kg/m2; p = 0.814)。结果:无骨水泥组的7年生存率(97.1%,95% CI 94.9-99.3)低于骨水泥组(97.8%,95% CI 96.6-99.0)。胫骨假体松动导致无骨水泥组5次翻修,而骨水泥组2次翻修(p结论:无骨水泥多孔钽tka在无菌松动方面的中期表现较差,促使其在本机构停止使用。
{"title":"Comparison of mid-term survival of uncemented total knee arthroplasties with modular tibial components made of porous tantalum vs. cemented total knee arthroplasties.","authors":"Žiga Godicelj, Jure Kastelic, Vesna Levašič, Zmago Krajnc, Andrej Moličnik, Igor Novak, Jakob Naranđa, Jan Zajc, Samo K Fokter","doi":"10.1080/17434440.2025.2569571","DOIUrl":"10.1080/17434440.2025.2569571","url":null,"abstract":"<p><strong>Background & objectives: </strong>Cementless total knee arthroplasties (TKAs) with porous tantalum tibial components were developed to improve fixation and reduce implant failure rates in younger, active patients. However, mid-term outcomes remain uncertain. This retrospective study compared survival rates of cementless TKAs with porous tantalum posterior-stabilized (PS) modular tibial components to cemented PS components from the same implant system, using revision for aseptic loosening as the endpoint.</p><p><strong>Materials and methods: </strong>From January 2017 to November 2021, 899 TKAs were performed at a single tertiary center for osteoarthritis. Of these, 645 (71.7%) were cemented and 254 (28.3%) cementless. Median BMI was similar in both groups (30.0 kg/m<sup>2</sup> vs 31.0 kg/m<sup>2</sup>; <i>p</i> = 0.814). Cementless recipients were younger (median 66.0 vs. 72.0 years; <i>p</i> < 0.001). Follow-up continued through 31 December 2023.</p><p><strong>Results: </strong>Seven-year survival was lower in the cementless group (97.1%, 95% CI 94.9-99.3) vs. cemented group (97.8%, 95% CI 96.6-99.0). Tibial component loosening led to 5 revisions in the cementless group vs. 2 revisions in the cemented group (<i>p</i> < 0.05). Two cementless cases involved tibial tray fractures. Overall, 86 patients (9.6%) died of unrelated causes.</p><p><strong>Conclusions: </strong>Cementless porous tantalum TKAs had inferior mid-term performance for aseptic loosening, prompting their discontinuation at our institution.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1415-1423"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrograde cerebral perfusion to support aortic arch repair. 逆行脑灌注支持主动脉弓修复。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-09-07 DOI: 10.1080/17434440.2025.2558203
Matti Jubouri, Mohamad Bashir, Mohammed Idhrees, Bashi Velayudhan, Ian M Williams, Damian M Bailey

Introduction: Acute type A aortic dissection (ATAAD) and aortic arch aneurysms are life-threatening conditions requiring complex surgical intervention, often involving circulatory arrest. Cerebral ischemia and neurological complications remain significant challenges in aortic arch surgery. This narrative review focuses on retrograde cerebral perfusion (RCP) techniques used to mitigate these risks.

Areas covered: This review article examines the evolution of cerebral protection strategies, with a focus on the techniques, parameters, and monitoring of RCP. It also compares RCP with antegrade cerebral perfusion (ACP) and deep hypothermic circulatory arrest (DHCA) regarding clinical outcomes.

Expert opinion: RCP has proven to be a valuable adjunct to DHCA in aortic arch surgery, offering comparable outcomes to ACP and demonstrating superiority over DHCA alone. Precise management of venous pressure and flow rate during RCP, along with meticulous cerebral monitoring, is crucial for optimizing neurological protection. Although ACP is increasingly favored in clinical practice, RCP continues to be a safe and effective cerebral protection strategy.

急性A型主动脉夹层(ATAAD)和主动脉弓动脉瘤是危及生命的疾病,需要复杂的手术干预,通常涉及循环骤停。脑缺血和神经系统并发症仍然是主动脉弓手术的重大挑战。这篇叙述性综述的重点是逆行脑灌注(RCP)技术用于减轻这些风险。涵盖领域:这篇综述文章探讨了脑保护策略的演变,重点是RCP的技术、参数和监测。它还比较了RCP与顺行性脑灌注(ACP)和深度低温循环停止(DHCA)的临床结果。专家意见:RCP已被证明是主动脉弓手术中DHCA的一种有价值的辅助手段,其疗效与ACP相当,且优于单独DHCA。在RCP过程中,精确管理静脉压力和流速,以及细致的大脑监测,对于优化神经保护至关重要。尽管ACP在临床实践中越来越受到青睐,但RCP仍然是一种安全有效的脑保护策略。
{"title":"Retrograde cerebral perfusion to support aortic arch repair.","authors":"Matti Jubouri, Mohamad Bashir, Mohammed Idhrees, Bashi Velayudhan, Ian M Williams, Damian M Bailey","doi":"10.1080/17434440.2025.2558203","DOIUrl":"10.1080/17434440.2025.2558203","url":null,"abstract":"<p><strong>Introduction: </strong>Acute type A aortic dissection (ATAAD) and aortic arch aneurysms are life-threatening conditions requiring complex surgical intervention, often involving circulatory arrest. Cerebral ischemia and neurological complications remain significant challenges in aortic arch surgery. This narrative review focuses on retrograde cerebral perfusion (RCP) techniques used to mitigate these risks.</p><p><strong>Areas covered: </strong>This review article examines the evolution of cerebral protection strategies, with a focus on the techniques, parameters, and monitoring of RCP. It also compares RCP with antegrade cerebral perfusion (ACP) and deep hypothermic circulatory arrest (DHCA) regarding clinical outcomes.</p><p><strong>Expert opinion: </strong>RCP has proven to be a valuable adjunct to DHCA in aortic arch surgery, offering comparable outcomes to ACP and demonstrating superiority over DHCA alone. Precise management of venous pressure and flow rate during RCP, along with meticulous cerebral monitoring, is crucial for optimizing neurological protection. Although ACP is increasingly favored in clinical practice, RCP continues to be a safe and effective cerebral protection strategy.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1341-1349"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145006911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacy. 采用Control-IQ技术的t:slim X2和Mobi胰岛素泵概述:患者安全性和设备有效性。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-11-05 DOI: 10.1080/17434440.2025.2585061
Alexandra Sawyer, Gregory P Forlenza, R Paul Wadwa

Introduction: Type 1 diabetes is a chronic disease requiring lifelong intensive insulin treatment. Automated insulin delivery (AID) systems such as Tandem Control-IQ allow for automatic adjustment of insulin delivery and can help improve glycemic outcomes.

Areas covered: This review will cover Tandem Control IQ AID technology and the Tandem t:slim X2 and Tandem Mobi insulin pumps including their physical features and function, the algorithm guiding insulin delivery, research regarding their safety and efficacy, and a brief overview of other AID systems. References were identified using PubMed.

Expert opinion: AID is now being considered as the standard for management of type 1 diabetes. Tandem Control IQ technology is one of several systems currently available that allows the user to benefit from the latest diabetes technology. Optimizing use of this system can lead to improved glycemic outcomes and decreased burden of disease for people with diabetes compared to multiple daily injections or open-loop insulin pump therapy.

1型糖尿病是一种需要终生胰岛素强化治疗的慢性疾病。自动胰岛素输送(AID)系统,如Tandem Control-IQ,允许胰岛素输送的自动调整,可以帮助改善血糖结果。涉及领域:本综述将涵盖Tandem Control IQ AID技术和Tandem T:Slim X2和Tandem Mobi胰岛素泵,包括它们的物理特性和功能,指导胰岛素输送的算法,关于它们的安全性和有效性的研究,以及其他AID系统的简要概述。使用PubMed确定参考文献。专家意见:AID现在被认为是管理1型糖尿病的标准。Tandem Control IQ技术是目前可用的几种系统之一,使用户可以从最新的糖尿病技术中受益。与每日多次注射或开环胰岛素泵治疗相比,优化使用该系统可改善糖尿病患者的血糖结局并减轻疾病负担。
{"title":"An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacy.","authors":"Alexandra Sawyer, Gregory P Forlenza, R Paul Wadwa","doi":"10.1080/17434440.2025.2585061","DOIUrl":"10.1080/17434440.2025.2585061","url":null,"abstract":"<p><strong>Introduction: </strong>Type 1 diabetes is a chronic disease requiring lifelong intensive insulin treatment. Automated insulin delivery (AID) systems such as Tandem Control-IQ allow for automatic adjustment of insulin delivery and can help improve glycemic outcomes.</p><p><strong>Areas covered: </strong>This review will cover Tandem Control IQ AID technology and the Tandem t:slim X2 and Tandem Mobi insulin pumps including their physical features and function, the algorithm guiding insulin delivery, research regarding their safety and efficacy, and a brief overview of other AID systems. References were identified using PubMed.</p><p><strong>Expert opinion: </strong>AID is now being considered as the standard for management of type 1 diabetes. Tandem Control IQ technology is one of several systems currently available that allows the user to benefit from the latest diabetes technology. Optimizing use of this system can lead to improved glycemic outcomes and decreased burden of disease for people with diabetes compared to multiple daily injections or open-loop insulin pump therapy.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1309-1321"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145427281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrafast 3D echocardiography: get fast or die tryin'. 超快3D超声心动图:要么快,要么死。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-10-13 DOI: 10.1080/17434440.2025.2573418
Olivier Villemain
{"title":"Ultrafast 3D echocardiography: get fast or die tryin'.","authors":"Olivier Villemain","doi":"10.1080/17434440.2025.2573418","DOIUrl":"10.1080/17434440.2025.2573418","url":null,"abstract":"","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1283-1285"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145254101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An update on the evidence for and against the use of intraocular lenses in infants and young children. 支持和反对婴幼儿使用人工晶状体的最新证据。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-10-30 DOI: 10.1080/17434440.2025.2579573
Taylor L DeHart, Rupal H Trivedi, M Edward Wilson

Introduction: One highly discussed topic in managing pediatric cataracts is determining when is it appropriate to implant an intraocular lens (IOL) in infants and young children who require cataract surgery. IOLs are an artificial replacement to the natural lens that may offer great visual benefit, but there are many factors to consider in the infant and young child population.

Areas covered: This review covers the evidence on primary IOL implantation in infants and young children with a special focus on visual benefit and complications to consider in the timing of IOL implantation. PubMed, Google Scholar, and Cochrane Library were searched for relevant articles, published between January 2016 and October 2024.

Expert opinion: Primary IOL implantation is preferred in children older than 6 months due to higher complication rates in younger infants. Future studies are needed to elucidate a predictable model for ocular growth in cataractous eyes and evaluate techniques and IOLs that may reduce visual axis opacification occurrence.

导言:在小儿白内障治疗中,一个被高度讨论的话题是,对于需要白内障手术的婴幼儿,何时适合植入人工晶状体(IOL)。人工晶状体是天然晶状体的人工替代品,可以提供很大的视力益处,但在婴幼儿人群中有许多因素需要考虑。涵盖领域:本文综述了婴幼儿一期人工晶状体植入术的证据,特别关注人工晶状体植入术时机的视力益处和并发症。PubMed, b谷歌Scholar和Cochrane Library检索了2016年1月至2024年10月之间发表的相关文章。专家意见:由于年龄较小的婴儿并发症发生率较高,6个月以上的儿童首选初级人工晶体植入术。未来的研究需要阐明白内障眼生长的可预测模型,并评估可能减少视轴混浊发生的技术和人工晶体。
{"title":"An update on the evidence for and against the use of intraocular lenses in infants and young children.","authors":"Taylor L DeHart, Rupal H Trivedi, M Edward Wilson","doi":"10.1080/17434440.2025.2579573","DOIUrl":"10.1080/17434440.2025.2579573","url":null,"abstract":"<p><strong>Introduction: </strong>One highly discussed topic in managing pediatric cataracts is determining when is it appropriate to implant an intraocular lens (IOL) in infants and young children who require cataract surgery. IOLs are an artificial replacement to the natural lens that may offer great visual benefit, but there are many factors to consider in the infant and young child population.</p><p><strong>Areas covered: </strong>This review covers the evidence on primary IOL implantation in infants and young children with a special focus on visual benefit and complications to consider in the timing of IOL implantation. PubMed, Google Scholar, and Cochrane Library were searched for relevant articles, published between January 2016 and October 2024.</p><p><strong>Expert opinion: </strong>Primary IOL implantation is preferred in children older than 6 months due to higher complication rates in younger infants. Future studies are needed to elucidate a predictable model for ocular growth in cataractous eyes and evaluate techniques and IOLs that may reduce visual axis opacification occurrence.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1323-1339"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145350559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing atrial fibrillation detection: a review of subcutaneous cardiac rhythm monitors and consumer technologies. 优化心房颤动检测:对皮下心律监测仪和消费者技术的回顾。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-11-16 DOI: 10.1080/17434440.2025.2580494
Michael Poliner, Rayyan Bhutta, Mahmoud Gomaa, Muhmmad R Afzal

Introduction: Subcutaneous cardiac rhythm monitors (SCRMs) are utilized for prolonged continuous rhythm monitoring to evaluate for arrhythmias in the setting of infrequent palpitations, syncope, and cryptogenic stroke. Managing SCRMs requires practices to screen incoming data and adjudicate electrocardiograms (ECG) for accuracy when arrhythmias are detected. The growing utilization of SCRMs has led to increased resource demands, exacerbated by false-positive (FP) episodes and data deluge. To address this issue, manufacturers have developed advanced algorithms with some integrating artificial intelligence (AI) into their software. In parallel, providers can implement customized device settings to potentially further reduce FP alerts.

Areas covered: This review will cover updates in SCRMs, addressing challenges with monitoring, cost effectiveness, and contemporary consumer products. Online databases were thoroughly searched for relevant studies.

Expert opinion: SCRMs are a valuable tool for prolonged rhythm monitoring. Advances in algorithms are aimed to reduce data deluge by a reduction in FP episodes. Providers can also utilize customized settings to further decrease the volume of FP events. Given the costs associated with SCRMs, some patients have turned to consumer devices as a more affordable but less robust alternative. Further advancements and studies are still necessary before consumer devices can be routinely integrated into clinical practice.

简介:皮下心律监测仪(SCRMs)用于长时间连续的心律监测,以评估在罕见心悸、晕厥和隐源性中风的情况下的心律失常。管理SCRMs需要对传入数据进行筛选,并在检测到心律失常时判定心电图的准确性。越来越多的SCRMs的使用导致了资源需求的增加,假阳性(FP)事件和数据泛滥加剧了资源需求。为了解决这个问题,制造商开发了先进的算法,其中一些将人工智能(AI)集成到他们的软件中。同时,供应商可以实现定制的设备设置,以潜在地进一步减少FP警报。涵盖领域:本综述将涵盖SCRMs的更新,解决监测、成本效益和当代消费产品方面的挑战。对在线数据库进行了全面的相关研究检索。专家意见:SCRMs是长时间节律监测的宝贵工具。算法的进步旨在通过减少FP事件来减少数据泛滥。提供者还可以利用自定义设置来进一步减少FP事件的数量。考虑到与scrm相关的成本,一些患者已经转向消费设备作为更实惠但不那么可靠的替代方案。在将消费设备常规地整合到临床实践之前,还需要进一步的进展和研究。
{"title":"Optimizing atrial fibrillation detection: a review of subcutaneous cardiac rhythm monitors and consumer technologies.","authors":"Michael Poliner, Rayyan Bhutta, Mahmoud Gomaa, Muhmmad R Afzal","doi":"10.1080/17434440.2025.2580494","DOIUrl":"10.1080/17434440.2025.2580494","url":null,"abstract":"<p><strong>Introduction: </strong>Subcutaneous cardiac rhythm monitors (SCRMs) are utilized for prolonged continuous rhythm monitoring to evaluate for arrhythmias in the setting of infrequent palpitations, syncope, and cryptogenic stroke. Managing SCRMs requires practices to screen incoming data and adjudicate electrocardiograms (ECG) for accuracy when arrhythmias are detected. The growing utilization of SCRMs has led to increased resource demands, exacerbated by false-positive (FP) episodes and data deluge. To address this issue, manufacturers have developed advanced algorithms with some integrating artificial intelligence (AI) into their software. In parallel, providers can implement customized device settings to potentially further reduce FP alerts.</p><p><strong>Areas covered: </strong>This review will cover updates in SCRMs, addressing challenges with monitoring, cost effectiveness, and contemporary consumer products. Online databases were thoroughly searched for relevant studies.</p><p><strong>Expert opinion: </strong>SCRMs are a valuable tool for prolonged rhythm monitoring. Advances in algorithms are aimed to reduce data deluge by a reduction in FP episodes. Providers can also utilize customized settings to further decrease the volume of FP events. Given the costs associated with SCRMs, some patients have turned to consumer devices as a more affordable but less robust alternative. Further advancements and studies are still necessary before consumer devices can be routinely integrated into clinical practice.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1351-1359"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lightening their load: considering overweight complications in patients with hip implants. 减轻负荷:考虑髋关节植入患者的超重并发症。
IF 2.7 Pub Date : 2025-12-01 Epub Date: 2025-09-29 DOI: 10.1080/17434440.2025.2567542
Maurice Weiss, Stefan Schroeder, Julian Zierke, Philipp Damm, Jan Philippe Kretzer
{"title":"Lightening their load: considering overweight complications in patients with hip implants.","authors":"Maurice Weiss, Stefan Schroeder, Julian Zierke, Philipp Damm, Jan Philippe Kretzer","doi":"10.1080/17434440.2025.2567542","DOIUrl":"10.1080/17434440.2025.2567542","url":null,"abstract":"","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1279-1281"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145180790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Expert review of medical devices
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1